The Effect of Vitamin D Supplementation on the Pulmonary Functions of Adult Asthmatic Egyptian Patients
Launched by CAIRO UNIVERSITY · Apr 20, 2016
Trial Information
Current as of June 10, 2025
Completed
Keywords
ClinConnect Summary
Asthmatic patients are recruited and divided into two groups. One receives Alfacalcidol beside their normal medications while the other acts as a control group receiving the normal asthma medication.
Both groups are followed up for four months.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Patients diagnosed with asthma
- • 2. Non-smokers
- Exclusion Criteria:
- • 1. Liver impairment
- • 2. Kidney impairment
- • 3. Patients receiving digoxin
- • 4. Known hypersensitivity to 1α-hydroxyvitamin D3, vitamin D or any of its analogues and derivatives
- • 5. Hypercalcaemia
- • 6. Hyperphosphatemia
- • 7. Pregnancy and breast-feeding
- • 8. Patients on nutritional supplements with a potential effect on 25(OH)D serum concentrations
- • 9. Had a History of stones in the urinary tract or diseases of calcium or bone metabolism
About Cairo University
Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Amani Ali
Principal Investigator
Faculty of pharmacy, Cairo university
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials